TABLE 5.
Variable | Recurrence-free survival |
Overall survival |
||||
---|---|---|---|---|---|---|
No. of patients | Median (95% CIa) | p | No. of patients | Median (95% CIa) | p | |
Hv1 expression | ||||||
High | 61 | 39.0 (34.3–43.7) | 0.000 | 61 | 40.1 (35.4–45.0) | 0.000 |
Low | 44 | 53.7 (50.1–57.4) | 44 | 54.1 (50.5–57.7) | ||
Age (years) | ||||||
≤50 | 48 | 48.7 (44.0–53.3) | 48 | 0.129 | 48.8 (44.3–53.4) | 0.373 |
>50 | 57 | 42.2 (37.4–47.1) | 57 | 43.6 (38.7–48.6) | ||
Primary site | ||||||
Left breast | 62 | 44.8 (40.2–49.4) | 0.731 | 62 | 46.0 (41.4–50.7) | 0.853 |
Right breast | 43 | 45.8 (40.7–50.9) | 43 | 46.1 (41.1–51.1) | ||
Tumor size (cm) | ||||||
≤2 | 26 | 51.5 (45.7–57.3) | 0.024 | 26 | 53.0 (47.3–58.7) | 0.009 |
>2 | 79 | 43.1 (39.1–47.1) | 79 | 43.7 (39.7–47.8) | ||
Lymph node status | ||||||
Negative | 64 | 50.5 (46.8–54.3) | 0.000 | 64 | 51.3 (47.6–54.9) | 0.000 |
Positive | 41 | 36.7 (31.1–42.3) | 41 | 37.8 (32.0–43.6) |
a CI indicates confidence interval.